Is a complete TOI research report available?

No complete published report is available for The Oncology Institute, Inc. (TOI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · USD

$5.07

+0.30 (+6.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TOI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	506.9M
Revenue (ttm)	545.8M
Net income (ttm)	-36.3M
EPS (ttm)	-$0.37
Shares out	100M
Volume	1,239,069
Beta	0.39
Price target	$8.40	+65.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 545.8M
Net income (ttm): -36.3M
EPS (ttm): -$0.37
Market cap: 506.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TOI indicators

Market & fundamental data

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001799191
Company name	The Oncology Institute, Inc.
Country	United States
Country code	US
Cusip	68236X100
Employees	641
Employees Change	-184%
Employees Change Percent	-22.3
Enterprise value	$580M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Industry PE	16.45
Industry PE Fwd	15.55
Isin	US68236X1000
Last refreshed	2026-07-31
Market cap	$506.9M
Market cap category	Small-Cap
Price	$5.07
Price currency	USD
Rev Per Employee	851,425.9x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	8011
Symbol	TOI
Website	https://theoncologyinstitute.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.19%
EV Sales Forward	0.83x
EV/Sales	1.06x
FCF yield	-5.09%
P/S ratio	0.93x
PS Forward	0.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.99%
EBITDA Margin	-4.75%
Gross margin	15.12%
Gross Profit	$82.5M
Gross Profit Growth	39.18%
Gross Profit Growth Q	35.17%
Gross Profit Growth3 Y	15.27%
Gross Profit Growth5 Y	15.52%
Net Income	$-36.3M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Pretax Margin	-8%
Profit Margin	-7.97%
Profit Per Employee	$-56,668
ROA	-12.3
Roa5y	-17.89
ROCE	-36.77
ROIC	-35.81
Roic5y	-127

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	40.09%
Cagr3y	75.86%
Cagr5y	-12.6%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth	35.37x
Revenue Growth Q	41.22x
Revenue Growth Quarters	20x
Revenue Growth Years	6x
Revenue Growth3 Y	25.89x
Revenue Growth5 Y	23.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.29
Assets	$168.2M
Cash	$30.3M
Current Assets	$116.9M
Current Liabilities	$79.4M
Debt	$104.9M
Equity	$-16.3M
Interest Coverage	-2.93
Liabilities	$184.5M
Long Term Assets	$51.4M
Long Term Liabilities	$105.2M
Net Cash	$-74.6M
Net Cash By Market Cap	$-14.77
Tangible Book Value	$-33.8M
Tangible Book Value Per Share	$-0.34
WACC	6.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	25.32
Net Working Capital	$14.7M
Quick ratio	1.13
Working Capital	$37.5M
Working Capital Turnover	$12.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.1%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	40.06%
200-day SMA	3.85
3Y total return	444.11%
50-day SMA	5.13
50-day SMA vs 200-day SMA	50over200
5Y total return	-48.99%
All Time High	12.66
All Time High Change	-59.95%
All Time High Date	2021-12-27
All Time Low	0.13
All Time Low Change	3,946.29%
All Time Low Date	2024-11-21
ATR	0.38
Beta	0.39
Beta1y	1.69
Beta2y	1.77
Ch YTD	42.42
High	5.18
High52	6.67
High52 Date	2026-07-14
High52ch	-23.99%
Low	4.8
Low52	2.32
Low52 Date	2026-02-13
Low52ch	118.53%
Ma50ch	-1.13%
Premarket Change Percent	-0.42
Premarket Price	$4.75
Premarket Volume	51,896
Price vs 200-day SMA	31.79%
RSI	46.61
RSI Monthly	62.67
RSI Weekly	60.76
Sharpe ratio	0.76x
Sortino ratio	1.3
Total Return	-30.1%
Tr YTD	42.42
Tr1m	-9.46%
Tr3m	36.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.06
Earnings Revenue Estimate	156,909,000x
Earnings Revenue Estimate Growth	30.97x
Operating Income	$-32.7M
Operating margin	-5.99
Price target	$8.4
Price Target Change	$65.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,240,540%
Float Percent	87.26%
Net Borrowing	-1,061,000
Shares Insiders	12.74%
Shares Institutions	47.8%
Shares Out	99,982,933
Shares Qo Q	0.34%
Shares Yo Y	30.1%
Short Float	8.34%
Short Ratio	3.29
Short Shares	7.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-30.5M
Adjusted OCF	-26,593,000
Average Volume	1,955,560.85x
Bv Per Share	-0.16
CAPEX	$-3.9M
Ch1m	-9.46
Ch1y	40.06
Ch3m	36.66
Ch3y	444.1
Ch5y	-48.99
Ch6m	77.27
Change	6.29%
Change From Open	4.75
Close	4.77
Days Gap	1.47
Depreciation Amortization	6,776,000
Dollar Volume	6,282,079.8
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-32.7M
EBITDA	$-25.9M
EPS	$-0.37
F Score	3
FCF	$-25.7M
FCF EV Yield	-4.44x
FCF Per Share	$-0.26
Financing CF	16,269,000
Fiscal Year End	December
Founded	2,007
Goodwill	7,230,000
Income Tax	$-131,000
Investing CF	-3,914,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	3.89
Ma150ch	30.37%
Ma20	5.45
Ma20ch	-6.94%
Net CF	-9,459,000
Next Earnings Date	2026-08-06
Open	4.84
Optionable	Yes
Position In Range	71.05
Post Close	5.07
Postmarket Change Percent	0.79
Postmarket Price	$5.11
Ppne	33,217,000
Pre Close	4.77
Price Date	2026-07-30
Relative Volume	0.63x
Revenue	545,764,000x
SBC By Revenue	0.88x
Share Based Comp	4,779,000
Tax By Revenue	-0.02x
Tr6m	77.27%
Us State	California
Volume	1,239,069
Z Score	1.56

The Oncology Institute, Inc. (TOI)

Coverage state: Market snapshot only — no published research

Generate the first TOI analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TOI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TOI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TOI

Frequently asked questions